Comparative pharmacokinetic study of Anisodamine Hydrobromide tablets and injection in septic acute lung injury rats-Reference-Cited by-同舟云学术

Comparative pharmacokinetic study of Anisodamine Hydrobromide tablets and injection in septic acute lung injury rats

Published:2024-08-08 Issue: Volume: Page:1-14
ISSN:1757-6180
Container-title:Bioanalysis
language:en
Short-container-title:Bioanalysis

Author:

Wu Rui¹,Zhang Fang¹,Liu Yanfang¹,Yu Yujie¹,Zhang Jianlan¹,Yao Chenhao¹,Dai Shu¹,Wan Feng¹²,Nan Feng³,Li Yunxia¹^ORCID

Affiliation:

1. State Key Laboratory of Southwestern Chinese Medicine Resources, Key Laboratory of Standardization for Chinese Herbal Medicine, Ministry of Education, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China

2. Chengdu NO. 1 Pharmaceutical Co., Ltd., Pengzhou, Sichuan, 610031, China

3. Drug Clinical Trial Institution, The Affiliated Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, 610075, China

Funder

Sichuan TCM Science and Technology Industry Innovation Team

the National Natural Science Foundation of China

Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine

Sichuan Province Science and Technology Support Program

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/17576180.2024.2383106

Reference47 articles.

1. The immunopathology of sepsis and potential therapeutic targets

2. Sepsis and septic shock

3. Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study

4. Anisodamine hydrobromide attenuates oxidative stress and proinflammatory cytokines in septic rats induced by cecal ligation and puncture

5. Update on the sources, pharmacokinetics, pharmacological action, and clinical application of anisodamine